MYLAN-NABUMETONE
MYLAN-NABUMETONE
Discontinued
DIN Number
02244563
Drug Class
Human
Market Date
Feb 20, 2002
Company
HC
Mylan Pharmaceuticals ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02244563
AIG Number0122821001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
M01AX01 NABUMETONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
NABUMETONEActive
Strength: 500 MG
Monograph: NABUMETONE